Abstract
Backgrounds: Limited data was reported for the frequency of SLE in China. The aim of this study was to investigate the frequency, geographical, and ethnic distributions of hospitalized SLE patients with data from the Hospital Quality Monitoring System (HQMS) in China. Methods: Hospitalized patients were investigated from a national inpatient database covering 46.0% of tertiary hospitals in China from 2013 to 2017. Data regarding the diagnosis of SLE were extracted based on ICD-10 codes. We collected and analyzed data from the front page of the records of inpatients, including frequency, demographic characteristics, and geographic distributions of SLE. Results: Among 158.3 million inpatients attended during the study period, 0.31% (491, 225) were diagnosed with SLE. The frequency of SLE decreased during the study period (from 0.30% in 2013 to 0.27% in 2017). The frequency of SLE increased with latitude (0.21% in northern China and 0.39% in southern China in 2017). Hospitalizations mostly occurred in winter (31.24%). The Li population had the highest frequency of patients with SLE (0.76%). The all-cause in-hospital mortality rate of SLE decreased from 0.74% (255/34,746) in 2013 to 0.54% (295/54,168) in 2017. The percentage of SLE patients with infections increased from 3.14% in 2013 to 4.72% in 2017. The percentage of SLE patients with tumors and thrombosis also increased slightly from 0.85 and 1.43% in 2013 to 1.27 and 2.45% in 2017, respectively. Conclusion: This study provided epidemiological information of SLE in hospitalized patients in China for the first time. An ethnic and spatial clustering trend of SLE was observed.
Introduction
Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease capable of damaging nearly any organ system. Despite its global prevalence, China—home to one of the world's largest SLE populations—has historically lacked comprehensive, nationwide epidemiological data. Previous research was often limited to small rural cohorts or single provinces, obscuring the true distribution of the disease across a vast and diverse nation. This study utilizes a high-volume national database to investigate the frequency, geographical distribution, and ethnic clustering of SLE, providing critical insights for healthcare planning and identifying at-risk populations.
Methods
This retrospective analysis utilized data from the Hospital Quality Monitoring System (HQMS), a standardized national inpatient database in China. The study encompassed records from 1,064 tertiary hospitals across 31 provinces, representing approximately 46% of all such facilities nationwide.
Researchers extracted SLE cases using ICD-10 codes (M32) from the "front page" of inpatient medical records. The dataset included 158.3 million inpatient records from 2013 to 2017. Variables analyzed included demographic information (age, sex, ethnicity), geographic location, seasonality of admission, and clinical outcomes such as mortality and complications (e.g., infection, thrombosis).
Results and Discussion
Geographic Distribution and the Latitude Gradient
A significant finding of this study is the geographic variation in SLE frequency. The data revealed a clear latitude gradient: the frequency of SLE was notably higher in southern China (0.39%) compared to northern China (0.21%).
This spatial clustering suggests that environmental factors, such as higher ultraviolet (UV) radiation exposure in the south, or regional genetic variations, may play a role in disease prevalence.
Ethnic Clustering
The study identified significant ethnic "hotspots." The Li, Dai, and Zhuang ethnic minorities exhibited the highest frequencies of SLE. Notably, the Li population had a frequency of 0.76%, which is nearly 2.5 times the national average.
Such strong ethnic clustering points toward a significant genetic component, potentially involving specific loci like TLR9 and HLA-DR2, which warrants further investigation through targeted Genome-Wide Association Studies (GWAS).
Temporal Trends and Clinical Outcomes
While the absolute number of SLE patients increased over the five-year period, the relative frequency (percentage of total hospitalizations) decreased from 0.30% in 2013 to 0.27% in 2017. This "frequency paradox" likely reflects a rapid expansion in general hospital admissions that outpaced the growth of the SLE inpatient population, or perhaps improvements in outpatient management.
Seasonally, hospitalizations peaked in winter (31.24%). This "winter flare" phenomenon might be linked to seasonal Vitamin D insufficiency or a higher incidence of viral triggers like the Epstein-Barr virus (EBV). Encouragingly, in-hospital mortality for SLE patients improved significantly, dropping from 0.74% in 2013 to 0.54% in 2017. However, the study noted an upward trend in complications, with infections rising from 3.14% to 4.72% and thrombosis increasing from 1.43% to 2.45%.
Limitations and Conclusion
This study provides the first comprehensive epidemiological map of SLE among hospitalized patients in China. However, it is subject to certain limitations. As the data is derived solely from tertiary hospital inpatients, it likely underestimates the total prevalence of SLE, as many stable patients are managed in outpatient settings. Furthermore, the "front page" data lacks granular clinical details necessary to fully understand the rising rates of certain complications.
In conclusion, the observed ethnic and spatial clustering of SLE in China highlights the need for region-specific healthcare strategies and further genetic research into high-risk populations.
Summary updated